The estrogen receptor and polyphenols: Molecular simulation studies of their interactions, a review

Environmental Chemistry Letters

Volumn 4, Issue 3, 2006, Pages 159-174

  Lambrinidis, George ^a   Halabalaki, Maria ^a   Katsanou, Efrosini S ^b   Skaltsounis, Alexios Leandros ^a   Alexis, Michael N ^b   Mikros, Emmanuel ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b INSTITUTE OF BIOLOGY   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33746500222     PISSN: 16103653     EISSN: 16103661     Source Type: Journal    
DOI: 10.1007/s10311-006-0065-y     Document Type: Review

References (88)

1. Abagyan R, Totrov M (2001) High-throughput docking for lead generation. Curr Opin Chem Biol 5:375-382
2. Adlercreutz H (2002) Phyto-oestrogens and cancer. Lancet Oncol 3:364-73
3. Adlercreutz H, Mazur W (1997) Phytoestrogens and western diseases. Ann Med 29:95-120
4. An J, Tzagarakis-Foster C, Scharschmidt TC, Lomri N, Leitman DC (2001) Estrogen receptor β-selective transcriptional activity and recruitment of coregulators by phytoestrogens. J Biol Chem 276:17808-17814
5. Anstead GM, Kym PR (1995) Benz[a]anthracene diols: Predicted carcinogenicity and structure-estrogen receptor binding affinity relationships. Steroids 60:383-394
6. Aqvist J, Medina C, Samuelsson JE (1994) A new method for predicting binding affinity in computer-aided drug design. Protein Eng 7:385-91
7. Babine RE, Bender SL (1997) Molecular recognition of protein-ligand complexes: Applications to drug design. Chem Rev 97:1359-1472
8. Bissantz C, Folkers G, Rognan D (2000) Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations. J Med Chem 43:4759-4767
9. Blair RM, Fang H, Branham WS, Hass BS, Dial SL, Moland CL, Tong W, Shi L, Perkins R, Sheehan DM (2000) The estrogen receptor relative binding affinities of 188 natural and xenochemicals: Structural diversity of ligands. Toxicol Sci 54:138-153
10. Blaney JM, Weiner PK, Dearing A, Kollman PA, Jorgensen EC, Oatley SJ, Burridge JM, Blake CCF (1982) Molecular mechanics simulation of protein-ligand interactions: Binding of thyroid hormone analogs to prealbumin. J Am Chem Soc 104:6424-34
11. Bohm HJ (1994) The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure. J Comput-Aided Mol Des 8:243-56
12. Breinholt V, Larsen JC (1998) Detection of weak estrogenic flavonoids using a recombinant yeast strain and a modified MCF7 cell proliferation assay. Chem Res Toxicol 11:622-629
13. Brzozowski AM, Pike ACW, Dauter Z, Hubbard RE, Bonn T, Engstrom O, Ohman L, Greene GL, Gustafsson J-A, Carlquist M (1997) Molecular basis of agonism and antagonism in the estrogen receptor. Nature (London) 389:753-758
14. Charifson PS, Corkery JJ, Murcko MA, Walters WP (1999) Consensus scoring: A method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins. J Med Chem 42:5100-5109
15. Charles GD, Bartels MJ, Zacharewski TR, Gollapudi BB, Freshour NL, Carney EW (2000) Activity of benzo[a]pyrene and its hydroxylated metabolites in an estrogen receptor-α reporter gene assay. Toxicol Sci 55:320-326
16. Clark RD, Strizhev A, Leonard JM, Blake JF, Matthew JB (2002) Consensus scoring for ligand/protein interactions. J Mol Graph Model 20:281-295
17. Dauvois S, Danielian PS, White R, Parker MG (1992) Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover. Proc Natl Acad Sci U. S. A. 89:4037-41
18. Dixon JS (1997) Evaluation of the CASP2 docking section. Proteins Suppl 1 198-204
19. Erickson JA, Jalaie M, Robertson DH, Lewis RA, Vieth M (2004) Lessons in molecular recognition: The effects of ligand and protein flexibility on molecular docking accuracy. J Med Chem 47:45-55
20. Feher M, Deretey E, Roy S (2003) BHB: A simple knowledge-based scoring function to improve the efficiency of database screening. J Chem Inf Comput Sci 43:1316-1327
21. Fokialakis N, Lambrinidis G, Mitsiou DJ, Aligiannis N, Mitakou S, Skaltsounis A-L, Pratsinis H, Mikros E, Alexis MN (2004) A New class of phytoestrogens. Evaluation of the estrogenic activity of deoxybenzoins. Chem Biol 11:397-406
22. Furr BJ, Jordan VC (1984) The pharmacology and clinical uses of tamoxifen. Pharmacol Ther 25:127-205
23. Gangloff M, Ruff M, Eiler S, Duclaud S, Wurtz JM, Moras D (2001) Crystal structure of a mutant hERα ligand-binding domain reveals key structural features for the mechanism of partial agonism. J Biol Chem 276:15059-15065
24. Gantchev TG, Ali H, van Lier JE (1994) Quantitative structure-activity relationships/comparative molecular field analysis (QSAR/CoMFA) for receptor-binding properties of halogenated estradiol derivatives. J Med Chem 37:4164-4176
25. Gao H, Katzenellenbogen JA, Garg R, Hansch C (1999) Comparative QSAR analysis of estrogen receptor ligands. Chem Rev 99:723-744
26. Greer J, Erickson JW, Baldwin JJ, Varney MD (1994) Application of the three-dimensional structures of protein target molecules in structure-based drug design. J Med Chem 37:1035-54
27. Grese TA, Sluka JP, Bryant HU, Cullinan GJ, Glasebrook AL, Jones CD, Matsumoto K, Palkowitz AD, Sato M, Termine JD, Winter MA, Yang NN, Dodge JA (1997) Molecular determinants of tissue selectivity in estrogen receptor modulators. Proc Natl Acad Sci USA 94:14105-14110
28. Halabalaki M (2005) PhD Thesis, University of Athens
29. Halabalaki M, Alexis X, Lambrinidis G, Aligiannis N, Pratsinis H, Florentin I, Mitaku S, Mikros E, Skaltsounis AL, Alexis MN (2005) submitted
30. Halgren TA, Murphy RB, Friesner RA, Beard HS, Frye LL, Pollard WT, Banks JL (2004) Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem 47:1750-1759
31. Halperin I, Ma B, Wolfson H, Nussinov R (2002a) Principles of docking: an overview of search algorithms and a guide to scoring functions. Proteins: Structure, function, and genetics 47:409-443
32. Halperin I, Ma B, Wolfson H, Nussinov R (2002b) Principles of docking: an overview of search algorithms and a guide to scoring functions. Proteins: Structure, function, and genetics 47:409-443
33. Harris HA, Bapat AR, Gonder DS, Frail DE (2002) The ligand binding profiles of estrogen receptors α and β are species dependent. Steroids 67:379-384
34. Howell A, Robertson JFR, Quaresma AJ, Aschermannova A, Mauriac L, Kleeberg UR, Vergote I, Erikstein B, Webster A, Morris C (2002) Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatment. J Clin Oncol 20:3396-403
35. Hurth KM, Nilges MJ, Carlson KE, Tamrazi A, Belford RL, Katzenellenbogen JA (2004) Ligand-induced changes in estrogen receptor conformation as measured by site-directed spin labeling. Biochemistry 43:1891-1907
36. Jacobsson M, Liden P, Stjernschantz E, Bostrom H, Norinder U (2003) Improving structure-based virtual screening by multivariate analysis of scoring data. J Med Chem 46:5781-9
37. Jones G, Willett P, Glen RC, Leach AR, Taylor R (1997) Development and validation of a genetic algorithm for flexible docking. J Mol Biol 267:727-748
38. Jordan VC (2003) Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents. J Med Chem 46:1081-1111
39. Jordan VC (2003) Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 1. Receptor interactions. J Med Chem 46:883-908
40. Jorgensen WL (2004) The many roles of computation in drug discovery. Science 303:1813-1818
41. Katsanou ES, Halabalaki M, Lambrinidis G, Aligiannis N, Mitakou S, Skaltsounis AL, Mikros E, Alexis X, Pratsinis H, Alexis MN (2005) submitted
42. Katzenellenbogen BS, Katzenellenbogen JA (2002) Biomedicine: Defining the "S" in SERMs. Science 295:2380-2381
43. Kearsley SK, Underwood DJ, Sheridan RP, Miller MD (1994) Flexibases: A way to enhance the use of molecular docking methods. J Comput-Aided Mol Des 8:565-82
44. Kollman PA (1996) Advances and continuing challenges in achieving realistic and predictive simulations of the properties of organic and biological molecules. Acc Chem Res 29:461-469
45. Kolossvary I, Guida WC (1996) Low mode search. An efficient, automated computational method for conformational analysis: Application to cyclic and acyclic alkanes and cyclic peptides. J Am Chem Soc 118:5011-5019
46. Kolossvary I, Guida WC (1999) Low-mode conformational search elucidated: application to C39H80 and flexible docking of 9-deazaguanine inhibitors into PNP. J Comput Chem 20:1671-1684
47. Kuiper GGJM, Carlsson B, Grandien K, Enmark E, Haeggblad J, Nilsson S, Gustafsson J-A (1997) Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138:863-870
48. Kuiper GGJM, Lemmen JG, Carlsson B, Corton JC, Safe SH, Van Der Saag PT, Van Der Burg B, Gustafsson J-A (1998) Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 139:4252-4263
49. Kuntz ID (1992) Structure-based strategies for drug design and discovery. Science 257:1078-82
50. Kuntz ID, Blaney JM, Oatley SJ, Langridge R, Ferrin TE (1982) A geometric approach to macromolecule-ligand interactions. J Mol Biol 161:269-88
51. Manas ES, Xu ZB, Unwalla RJ, Somers WS (2004) Understanding the selectivity of genistein for human estrogen receptor-β using X-Ray crystallography and computational methods. Structure 12:2197-2207
52. Moggs JG, Orphanides G (2001) Estrogen receptors: Orchestrators of pleiotropic cellular responses. EMBO Rep 2:775-781
53. Mohamadi F, Richards NGJ, Guida WC, Liskamp R, Lipton M, Caufield C, Chang G, Hendrickson T, Still WC (1990) MacroModel - an integrated software system for modeling organic and bioorganic molecules using molecular mechanics. J Comput Chem 11:440-67
54. Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ (1998) Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem 19:1639-1662
55. Muegge I, Martin YC (1999) A general and fast scoring function for protein-ligand interactions: A simplified potential approach. J Med Chem 42:791-804
56. Muegge I, Rarey M (2001) Small molecule docking and scoring. Rev Comput Chem 17:1-60
57. Muthyala RS, Ju YH, Sheng S, Williams LD, Doerge DR, Katzenellenbogen BS, Helferich WG, Katzenellenbogen JA (2004) Equol, a natural estrogenic metabolite from soy isoflavones convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta. Bioorg Med Chem 12:1559-1567 and references therein
58. Nam K, Marshall P, Wolf RM, Cornell W (2003) Simulation of the different biological activities of diethylstilbestrol (DES) on estrogen receptor α and estrogen-related receptor γ. Biopolymers 68:130-138
59. Nettles KW, Sun J, Radek JT, Sheng S, Rodriguez AL, Katzenellenbogen JA, Katzenellenbogen BS, Greene GL (2004) Allosteric control of ligand selectivity between estrogen receptors α and β: Implications for other nuclear receptors. Molecular Cell 13:317-327
60. Oostenbrink BC, Pitera JW, van Lipzig MMH, Meerman JHN, van Gunsteren WF (2000) Simulations of the estrogen receptor ligand-binding domain: affinity of natural ligands and xenoestrogens. J Med Chem 43:4594-4605
61. Pike ACW, Brzozowski AM, Hubbard RE, Bonn T, Thorsell A-G, Engstrom O, Ljunggren J, Gustafsson J-A, Carlquist M (1999) Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J 18:4608-4618
62. Pike ACW, Brzozowski AM, Walton J, Hubbard RE, Thorsell A-G, Li Y-L, Gustafsson J-A, Carlquist M (2001) Structural insights into the mode of action of a pure antiestrogen. Structure 9:145-153
63. Rarey M, Kramer B, Lengauer T, Klebe G (1996) A fast flexible docking method using an incremental construction algorithm. J Mol Biol 261:470-489
64. Sadler BR, Cho SJ, Ishaq KS, Chae K, Korach KS (1998) Three-dimensional quantitative structure-activity relationship study of nonsteroidal estrogen receptor ligands using the comparative molecular field analysis/ cross-validated r2-guided region selection approach. J Med Chem 41:2261-2267
65. Schapira M, Abagyan R, Totrov M (2003) Nuclear hormone receptor targeted virtual screening. J Med Chem 46:3045-3059
66. Schapira M, Totrov M, Abagyan R (1999) Prediction of the binding energy for small molecules, peptides and proteins. J Mol Recognit 12:177-190
67. Schulz-Gasch T, Stahl M (2003) Binding site characteristics in structure-based virtual screening: Evaluation of current docking tools. J Mol Model 9:47-57
68. Setchell KDR, Cassidy A (1999) Dietary isoflavones: Biological effects and relevance to human health. J Nutr 129:758S-767S
69. Shang Y, Brown M (2002) Molecular determinants for the tissue specificity of SERMs. Science 295:2465-2468
70. Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA, Greene GL (1998) The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95:927-37
71. Shiau AK, Barstad D, Radek JT, Meyers MJ, Nettles KW Katzenellenbogen BS, Katzenellenbogen JA, Agard DA, Greene GL (2002) Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism. Nat Struct Biol 9:359-364
72. Sippl W (2000) Receptor-based 3D QSAR analysis of estrogen receptor ligands-merging the accuracy of receptor-based alignments wit the computational efficiency of ligand-based methods. J Comput-Aided Mol Des 14:559-572
73. Soto AM, Sonnenschein C, Chung KL, Fernandez MF, Olea N, Serrano FO (1995) The E-SCREEN assay as a tool to identify estrogens: An update on estrogenic environmental pollutants. Environ Health Perspect 103(Suppl 7):113-22
74. Stahl M, Rarey M (2001) Detailed analysis of scoring functions for virtual screening. J Med Chem 44:1035-1042
75. Stevens RC, Yokoyama S, Wilson LA.(2001) Global efforts in structural genomics. Science 294:89-92
76. Stewart JJP (1990) MOPAC: A semiempirical molecular orbital program. J Comput-Aided Mol Des 4:1-105
77. Sun L, Zhou Y, Genrong L, Li SZ (2004) Molecular electronegativity-distance vector (MEDV-4): A two-dimensional QSAR method for the estimation and prediction of biological activities of estradiol derivatives. J Mol Struct (Theochem) 679:107-113
78. Tamrazi A, Carlson KE, Katzenellenbogen JA (2003) Molecular sensors of estrogen receptor conformations and dynamics. Mol Endocrinol 17:2593-2602
79. van Lipzig MMH, Ter Laak AM, Jongejan A, Vermeulen NPE, Wamelink M, Geerke D, Meerman JHN (2004) Prediction of ligand binding affinity and orientation of xenoestrogens to the estrogen receptor by molecular dynamics simulations and the linear interaction energy method. J Med Chem 47:1018-1030
80. Vedani A, Huhta DW (1990) A new force field for modeling metalloproteins. J Am Chem Soc 112:4759-67
81. Verdonk ML, Berdini V, Hartshorn MJ, Mooij WTM, Murray CW, Taylor RD, Watson P (2004) Virtual screening using protein-ligand docking: Avoiding artificial enrichment. J Chem Inf Comput Sci 44:793-806
82. Waller CL (2004) A comparative QSAR study using CoMFA, HQSAR, and FRED/ SKEYS paradigms for estrogen receptor binding affinities of structurally diverse compounds. J Chem Inf Comput Sci 44:758-765
83. Waller CL, Oprea TI, Chae K, Park H-K, Korach KS, Laws SC, Wiese TE, Kelce WR, Gray LE Jr (1996) Ligand-based identification of environmental estrogens. Chem Res Toxicol 9:1240-1248
84. Wiese TE, Polin LA, Palomino E, Brooks SC (1997) Induction of the estrogen specific mitogenic response of MCF-7 cells by selected analogs of estradiol-17β: A 3D QSAR study. J Med Chem 40:3659-3669
85. Wolohan P, Reichert DE (2004) Use of binding energy in comparative molecular field analysis of isoform selective estrogen receptor ligands. J Mol Graphics Model 23:23-38
86. Writing Group for the Women's Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the women's health initiative randomized controlled trial
87. Zavodszky MI, Lei M, Thorpe MF, Day AR, Kuhn LA (2004) Modeling correlated main-chain motions in proteins for flexible molecular recognition. Proteins: Structure, function, and bioinformatics 57:243-261
88. Zbinden P, Dobler M, Folkers G, Vedani A (1998) PrGem: Pseudoreceptor modeling using receptor-mediated ligand alignment and pharmacophore equilibration. Quant Struct-Act Relat 17:122-130